Hanseatic Management Services’s Ionis Pharmaceuticals IONS Stock Holding History

Hanseatic Management Services’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,811	Closed	-$408K	–	126
2022 Q4	$408K	Sell	10,811 -182	-2%	-$7.66K	1.03%	35
2022 Q3	$486K	Sell	10,993 -229	-2%	-$9.65K	1.31%	26
2022 Q2	$415K	Buy	+11,222	New	+$423K	0.94%	37
2019 Q4	–	Sell	-8,314	Closed	-$498K	–	248
2019 Q3	$498K	Hold	8,314	–	–	0.51%	82
2019 Q2	$534K	Sell	8,314 -315	-4%	-$22.3K	0.54%	76
2019 Q1	$700K	Buy	8,629 +489	+6%	+$31.5K	0.73%	51
2018 Q4	$440K	Buy	+8,140	New	+$415K	0.59%	67
2018 Q2	–	Sell	-668	Closed	-$29K	–	424
2018 Q1	$29K	Sell	668 -3,486	-84%	-$177K	0.03%	208
2017 Q4	$209K	Buy	4,154 +1,210	+41%	+$66.4K	0.21%	120
2017 Q3	$149K	Sell	2,944 -537	-15%	-$28.1K	0.17%	120
2017 Q2	$177K	Buy	3,481 +41	+1%	+$1.91K	0.09%	145
2017 Q1	$138K	Buy	+3,440	New	+$154K	0.08%	159
2016 Q1	–	Sell	-16,161	Closed	-$1M	–	270
2015 Q4	$1M	Buy	+16,161	New	+$872K	0.35%	93

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Hanseatic Management Services's IONS Position: Q1 2023 in Review

Hanseatic Management Services sold out of Ionis Pharmaceuticals (IONS) in Q1 2023, closing a stake of 10,811 shares — an estimated $408K sold.

Hanseatic Management Services first reported a position in IONS in Q4 2015 and held it in 13 quarters. The position peaked at $1M in Q4 2015. 313 funds tracked by Wall St. Rank hold IONS as of Q1 2023.

Hanseatic Management Services reported no remaining Ionis Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Hanseatic Management Services sold 10,811 Ionis Pharmaceuticals shares in Q1 2023, an estimated $408K.
Hanseatic Management Services first reported a position in Ionis Pharmaceuticals in Q4 2015 and held it in 13 quarters.
Hanseatic Management Services's Ionis Pharmaceuticals position peaked at $1M in Q4 2015.
313 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2023.

Based on Hanseatic Management Services's 13F filing for Q1 2023, filed 12 May 2023.